MS Tallman
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 10
- Chronic Lymphocytic Leukemia Research 10
-
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 4
- Journals
- Blood (14 papers)Leukemia (1 paper)PubMed (4 papers)
- Partner nations
- United StatesJapanVietnam
In The Last Decade
MS Tallman
18 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 72
- Hematology 562
- Genetics 460
- Oncology 629
- Pathology and Forensic Medicine 350
- Cancer Research 265
Countries citing papers authored by MS Tallman
This map shows the geographic impact of MS Tallman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MS Tallman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MS Tallman more than expected).
Fields of papers citing papers by MS Tallman
This network shows the impact of papers produced by MS Tallman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MS Tallman. The network helps show where MS Tallman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside MS Tallman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 16 | |
| 2 | Roundtable discussion: Incorporating bone marrow transplantation into NCCN guidelines. | 1998 | 1 |
| 3 | 1996 | 78 | |
| 4 | Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia. | 1996 | 19 |
| 5 | 1996 | 68 | |
| 6 | 1996 | 60 | |
| 7 | Current results and prospective trials of cladribine in chronic lymphocytic leukemia. | 1996 | 1 |
| 8 | 1995 | 82 | |
| 9 | 1995 | 124 | |
| 10 | 1995 | 2 | |
| 11 | 1993 | 308 | |
| 12 | 1993 | 389 | |
| 13 | 1993 | 48 | |
| 14 | 1993 | 3 | |
| 15 | 1992 | 6 | |
| 16 | 1992 | 233 | |
| 17 | 1992 | 94 | |
| 18 | 1992 | 0 | |
| 19 | Innovations in Urologic Oncology: Selected Papers from a Northwestern University Cancer Center Symposium | 1991 | 1 |
| 20 | Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patients. | 1988 | 1 |
About MS Tallman
MS Tallman is a scholar working on Genetics, Hematology, Immunology, Oncology and Dermatology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (5 papers), Viral-associated cancers and disorders (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Hematology (562 citations), Genetics (460 citations), Oncology (629 citations), Pathology and Forensic Medicine (350 citations) and Cancer Research (265 citations). MS Tallman has collaborated with scholars based in United States, Japan and Vietnam. Frequent co-authors include H.C. Kwaan, H M Lazarus, BW Cooper, NE Davidson, MJ Kennedy, David Hakimian, TJ Moss, Moss Tj, Esther Rose and LoAnn Peterson. Their work appears in journals such as Blood, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.